Skip to main content

Table 3 Number of syncope hospital admissions, diagnosed patients and costs for ILR and CDP groups in different scenarios

From: Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal

Model output

ILR

CDP

Overall savings

Time horizon

Lifetime

3 years

Lifetime

3 years

Lifetime

3 years

Number of patients diagnosed

175

135

143

40

32

95

Number of patients undiagnosed and alive

1

58

2

152

-1

-94

Total syncope episodes

531

215

1,141

315

610

100

Number of injuries (major and minor)

278

112

596

165

318

53

Costs – device acquisition

394,000€

394,000€

0€

0€

-394,000€

-394,000€

Costs – device-related expenses

71,101€

71,101€

0€

0€

-71,101€

-71,101€

Costs – syncope admissions

705,292€

353,756€

1,431,910€

513,879€

726,618€

160,123€

Costs – diagnostic tests*

34,228€

0€

139,422€

50,035€

105,194€

50,035€

Costs – total (Sousa Pedro)

1,204,621€

818,857€

1,571,332€

563,915€

366,711€

-254,943€

Costs – total (Edvardsson)

1,402,037€

818,857€

2,375,465€

852,499€

973,429€

33,642€

Costs – total (Baron-Esquivias)

1,188,830€

818,857€

1,507,011€

540,831€

318,181€

-278,026€

Costs – total (Brignole)

1,206,495€

818,857€

1,578,965€

566,654€

372,470€

-252,203€

Costs – total (Farwell)

1,185,476€

818,857€

1,493,347€

535,928€

307,872€

-282,929€

  1. *Diagnostic test costs calculated from resource use data reported by Sousa Pedro [24]. The ‘total’ results for Edvardsson, Baron-Esquivias, Brignole and Farwell instead use the diagnostic test resource use data from the respective studies.